SCHEMBL4273722

SCHEMBL4273722

O=C1c2ccccc2C(=O)N1Cc1coc(-c2ccc(OC(F)F)c(OCc3ccccc3)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
KMT2A Q03164 2/20 0.38
PDE4B Q07343 4/20 0.38
CASP3 P42574 1/20 0.37
TSHR P16473 4/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DRD2 P14416 2/20 0.37
DRD4 P21917 2/20 0.37
DRD3 P35462 2/20 0.37
PTGER1 P34995 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19066469 1.00 ADRA1D (0.39) ADRA1DADRA1AKMT2APDE4BCASP3
SCHEMBL4278443 0.88 KDM4E (0.47) KMT2APDE4BTSHRALDH1A1KDM4E
SCHEMBL15521514 0.87 ADRA1D (0.42) ADRA1DADRA1AKMT2ATSHRALDH1A1
SCHEMBL24297148 0.86 ADRA1D (0.44) ADRA1DADRA1AKMT2ATSHRALDH1A1
SCHEMBL17037218 0.86 ADRA1A (0.50) ADRA1DADRA1AKMT2ATSHRALDH1A1
SCHEMBL31239065 0.86 ADRA1A (0.50) ADRA1DADRA1AKMT2ATSHRALDH1A1
SCHEMBL31239024 0.84 ADRA1D (0.41) ADRA1DADRA1AKMT2ACASP3TSHR
SCHEMBL19066428 0.84 ADRA1D (0.41) ADRA1DADRA1AKMT2ACASP3TSHR
SCHEMBL17037230 0.83 TSHR (0.41) KMT2APDE4BTSHRALDH1A1KDM4E
SCHEMBL4280199 0.83 TSHR (0.41) KMT2APDE4BTSHRALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260108497-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICALC., LTD. (JP) 2026-04-23 US disclosed
US-20240366573-A1 OINTMENT CONTAINING AN OXAZOLE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-11-07 US disclosed
US-20240148699-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-05-09 US disclosed
US-20220265613-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-08-25 US disclosed
US-20220117944-A1 OINTMENT CONTAINING AN OXAZOLE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-04-21 US disclosed
US-20200078340-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2020-03-12 US disclosed
US-20190070151-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2019-03-07 US disclosed
US-RE46792-E1 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-04-17 US disclosed
US-20170216260-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-08-03 US disclosed
EP-1954684-B1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMA CO LTD (JP) 2014-05-07 EP disclosed
US-20140100226-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-04-10 US disclosed
US-8637559-B2 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-01-28 US disclosed
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-09-03 US disclosed
EP-1954684-A2 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION Otsuka Pharmaceutical Co., Ltd. (JP) 2008-08-13 EP disclosed
WO-2007058338-A9 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMA CO LTD (JP) 2007-11-01 WO disclosed
WO-2007058338-A2 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216260-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A ADRA1D 33/4885ADRA1A 25/4885KMT2A 2947/4885
US-20140100226-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A ADRA1D 33/4885ADRA1A 25/4885KMT2A 2947/4885
US-20240366573-A1 OINTMENT CONTAINING AN OXAZOLE COMPOUND PDE12, PDE4B, PDE4A ADRA1D 478/4885ADRA1A 491/4885KMT2A 3513/4885
US-20240148699-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A ADRA1D 33/4885ADRA1A 25/4885KMT2A 2947/4885
US-20260108497-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE7B, PDE4B, PDE1B ADRA1D 143/4885ADRA1A 434/4885KMT2A 3262/4885
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A ADRA1D 33/4885ADRA1A 25/4885KMT2A 2947/4885
US-20220117944-A1 OINTMENT CONTAINING AN OXAZOLE COMPOUND PDE12, PDE4B, PDE4A ADRA1D 478/4885ADRA1A 491/4885KMT2A 3513/4885
US-20200078340-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A ADRA1D 33/4885ADRA1A 25/4885KMT2A 2947/4885
US-20220265613-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A ADRA1D 36/4885ADRA1A 27/4885KMT2A 3157/4885
US-20190070151-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A ADRA1D 33/4885ADRA1A 25/4885KMT2A 2947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.